High Quality Finasteride for Treatment of Hair Loss

High Quality Finasteride for Treatment of Hair Loss

Model NO.: CAS NO.: 98319-26-7
Appearance: White or White Crystalline Solid
Trade name: Propecia, Proscar
Purity assay: 99%
Standard: USP
Chat Now

Product Details

Basic Info
Model NO.: CAS NO.: 98319-26-7
Appearance: White or White Crystalline Solid
Trade name: Propecia, Proscar
Purity assay: 99%
Standard: USP
Grade: Pharmaceutical Grade
Molecular Weight: 372.54
Molecular Formula: C23H36N2O2
Supply ability: 1000kg/month and more
Package: Secret Packing
Delivery Time: one working day after payment confirmed
Trademark: Muscle Man
Transport Package: Foil Bag, or as Your Demand
Specification: 99%
Origin: China


Product Description
Finasteride, a 4- nitrogen heterocyclic compound, is a specific inhibitor of the intracellular enzyme -II 5a- reductase in the process of testosterone metabolism that is a stronger two testosterone. Benign prostatic hyperplasia, or prostatic hypertrophy, is determined by the transformation of testosterone into two hydrogen testosterone in the prostate. This medicine can effectively reduce two hydrogen testosterone in blood and prostate. Finasteride has no affinity to androgen receptor.

In a long-term study of the efficacy and safety of the drug (PLESS), 3016 patients with moderate to severe prostatic hyperplasia were treated with prostatic hyperplasia related urological treatment (surgical intervention), such as transurethral resection of the prostate and other prostatectomy, or acute urinary retention requiring catheter insertion. The evaluation was carried out. In this double blind, randomized, placebo-controlled multicenter study, the overall risk of urinary system treatment was reduced by 51% with this drug treatment, accompanied by a significant and sustained reduction in the volume of the prostate, as well as the continued maximum flow rate and symptom improvement.

Finasteride is a 4- nsteroid hormone compound, a specific type II type 5 alpha reductase inhibitor, inhibiting the conversion of peripheral testosterone to two hydrotestosterone, and reducing the level of two hydrotestosterone in blood and prostate, skin and other tissues. The growth and benign prostatic hyperplasia of the prostate is dependent on the two hydrotestosterone, which inhibits the prostatic hyperplasia and improves the clinical symptoms of benign prostatic hyperplasia by reducing the level of the blood and the two hydrotestosterone in the prostate tissue.


COA

Product name

Finasteride

CAS No.

98319-26-7

Outer Packing

1KG/drum

Production date

Jun.,01, 2017

Shelf life

May.,31, 2022

Standard adopted

USP38

Items of analysis

Specification

Results

Description

white or almost white crystalline powder

almost white crystalline powder

Identification(IR,HPLC)

complies with the standard

complies

Solubility

Free soluble in chloroform and in alcohol ,very slightly soluble in water.

complies

Melting point

About 257ºC

256.0~257.0ºC

Specific rotation

-56.0°~-60.0°

-58.4°

Water

max.0.3%

0.25%

Residue on ignition

max.0.1%

0.04%

Heavy Metals

max.10ppm

complies

Loose Density (g/cm3)

0.27~0.37

0.31

Tapped Density (g/cm3)

0.40~0.56

0.52

Particle size

100%≤20um 90%≤10um

complies

Any individual impurity

max.0.5%

0.12%

Total impurities

max.1.0%

0.44%

Assay (HPLC, based on drying)

98.5%~101.0%

99.2%

Acetone

Max.5000ppm

complies

Chloroform

Max.60ppm

complies

THF

Max.720ppm

complies

Dichloromethane

Max.600ppm

complies

Toluene

Max.890ppm

complies

Methanol

Max3000ppm

complies

Organic volatile substances

Meet the ICH requirements

complies

Conclusion

Qualified

Inquiry